Using BNP to diagnose, manage, and treat heart failure

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 4, 2003, Pages 333-336

  Hobbs, Robert E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; NATRIURETIC PEPTIDE TYPE C; NESIRITIDE; NITRIC ACID DERIVATIVE; SPIRONOLACTONE;

ARTICLE; ASSAY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST CONTROL; COST OF ILLNESS; DIAGNOSTIC KIT; DIAGNOSTIC TEST; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; HEART ARRHYTHMIA; HEART FAILURE; HEMODYNAMICS; HOSPITAL DISCHARGE; HUMAN; MEDICAL DECISION MAKING; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT OUTCOME;

EID: 0037738906     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.4.333     Document Type: Article

References (4)

1. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106:416-422.
2. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001; 37:379-385.
3. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-167.
4. Publication Committee for the VMAC investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002; 287:1531-1540.